Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00004306 · ClinicalTrials.gov registry record
Clinical and Molecular Correlations in Spinocerebellar Ataxia Type 10 (SCA10)
A clinical trial of Hereditary Ataxia, sponsored by Office of Rare Diseases (ORD).
- Completed
- Registry status
- 18
- Enrollment target
- 1
- Study location
NCT00004306: Completed study of Hereditary Ataxia, sponsored by Office of Rare Diseases (ORD).
NCT00004306 is a study of Hereditary Ataxia that has completed, run by Office of Rare Diseases (ORD). The registered enrollment target is 18 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00004306, a study of Hereditary Ataxia, has completed, sponsored by Office of Rare Diseases (ORD).
- COMPLETED
- Registry status
- 18 participants
- Enrollment target
- 1
- Study location
Study Summary
OBJECTIVES: I. Clinically evaluate members from families with a dominantly inherited ataxia and collect blood, skin and muscle samples for detailed molecular studies. II. Perform detailed clinical evaluations on patients with recessively inherited ataxias.
Conditions Studied
Study Locations (1)
Texas
- University of Texas Medical Branch at Galveston - Galveston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18 participants |
| Start Date | 1999-11 |
| Est. Completion | 2009-03 |
What the finished NCT00004306 record still lists
NCT00004306 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 18 participants, a relatively small participant target.
The record links to 1 condition, with Hereditary Ataxia appearing as the primary indexed condition, and to 0 interventions.
NCT00004306 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT00004306 about?
NCT00004306 is a clinical study titled "Clinical and Molecular Correlations in Spinocerebellar Ataxia Type 10 (SCA10)". OBJECTIVES: I. Clinically evaluate members from families with a dominantly inherited ataxia and collect blood, skin and muscle samples for detailed molecular studies. II. Perform detailed clinical evaluations on patients with recessively inherited ataxias.
What is the current status of trial NCT00004306?
This trial is currently completed. The enrollment target is 18 participants. The study started on 1999-11. Estimated completion is 2009-03.
What conditions does trial NCT00004306 study?
This clinical trial studies the following conditions: Hereditary Ataxia.
Who is sponsoring clinical trial NCT00004306?
This trial is sponsored by Office of Rare Diseases (ORD), which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00004306 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01245179 · 18 participants · Phase 1
Study of Panobinostat (LBH589) in Patients With Sickle Cell Disease
- NCT01999361 · 18 participants · NA
Prevention of de Novo Allosensitization in Islet Transplant Recipients Following Complete Graft Loss
- NCT02359825 · 18 participants · Phase 1
Nerve Repair Using Hydrophilic Polymers to Promote Immediate Fusion of Severed Axons and Swift Return of Function
- NCT02870244 · 18 participants · Phase 1
Adoptive T Cell Immunotherapy for Advanced Melanoma Using Engineered Lymphocytes
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia